Measurement of the Distribution of Optical Properties in Adult Human Muscle

Muscle Disorder Clinical Trial

Official title:

Measurement of the Distribution of Optical Properties in Adult Human Muscle

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00540683
• Other study ID #: 20043626
• Status: Withdrawn
• Start date: October 2004
• Est. completion date: July 2018

Study information

• Verified date: October 2022
• Source: University of California, Irvine
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The researcher can use Diffuse Optical spectroscopy technique that uses harmless levels of near-infrared light to probe the concentrations and states of important physiological molecules such as hemoglobin water and lipids in human muscle,.

Description:

The researcher can monitor muscle physiology, for example during exercise or in response to external factors such as shock by Diffuse Optical spectroscopy technique.

The Diffuse Optical spectroscopy technique can determine significant changes in muscle, muscle structure, muscle tissues metabolism and hemodynamics.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: July 2018
• Est. primary completion date: July 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Male or Female age 18 years and older

• Diagnosed of Cachexic condition

• Diagnosed of Cellulite adult female 18 years and older

Exclusion Criteria:

• Pregnant women

• Taking light sensitive drugs for use in photodynamic therapy

Related Conditions & MeSH terms

• Muscle Disorder
• Muscular Diseases

Intervention

Device:
• Diffuse Optical Spectroscopy
Muscle properties

Locations

Country	Name	City	State
United States	Beckman Laser Institute University of California Irvine	Irvine	California

Sponsors (2)

Lead Sponsor	Collaborator
University of California, Irvine	Beckman Laser Institute University of California Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Healthy Muscle		upto 4 weeks